Stockreport

Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Itovebi™ (inavolisib) [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF partner by Genentech, a member of the Roche Group, for ITOVEBI ™ (inavolisib) which is indicated, in combination with palbociclib and fulvestrant, for the treatment of a [Read more]